期刊文献+

Diagnostic accuracy of administrative database for bile duct cancer by ICD-10 code in a tertiary institute in Korea

下载PDF
导出
摘要 Background:Administrative database provides valuable information for large cohort studies,especially when tissue diagnosis is rather difficult such as the diagnosis for bile duct cancer(BDC).The aim of this study was to evaluate the diagnostic accuracy of administrative database for BDC by International Classification of Diseases(ICD)-10 codes in a tertiary institute.Methods:BDC and control groups were collected from 2003 to 2016 at Seoul National University Bundang Hospital.Cases of BDC were identified in the National Health Insurance Service(NHIS)database by ICD 10-code supported by V code.The control group was selected from cases without ICD-10 codes for BDC.A definite or possible diagnosis was defined according to pathologic reports.Medical records,images,and pathology reports were analyzed to evaluate ICD-10 codes for BDC.Sensitivity,specificity,positive predictive value,and negative predictive value for BDC were analyzed according to diagnostic criteria and cancer locations.Results:A total of 1707 patients with BDC and 1707 controls were collected.Among those with BDC,1320(77.3%)were diagnosed by definite criteria.Most(99.4%)of them had adenocarcinoma.Rate of definite diagnosis was the highest for ampulla of Vater(88.9%),followed by that for extrahepatic(84.9%)and intrahepatic(68.3%)BDCs.False positive cases commonly had hepatocellular carcinomas.For overall diagnosis of BDC,sensitivity,specificity,positive predictive value,and negative predictive value were 99.94%,98.33%,98.30%,and 99.94%,respectively.Diagnostic accuracies were similar regardless of diagnostic criteria or tumor locations.Conclusions:Administrative database for BDC collected according to ICD-10 code with V code shows good accuracy.
出处 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS CSCD 2020年第6期575-580,共6页 国际肝胆胰疾病杂志(英文版)
基金 a grant from the National Research Foundation of Korea(NRF)(No.2011-0030001) the Global Core Research Center(GCRC)funded by the Korean government(MSIP).
  • 相关文献

参考文献3

二级参考文献149

  • 1Bai-He Zhang, Qing-Bao Cheng, Xiang-Ji Luo, Yong-Jie Zhang, Xiao-Qing Jiang, Bao-Hua Zhang, Bin Yi, Wen-Long Yu and Meng-Chao Wu Department of Biliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.Surgical therapy for hiliar cholangiocarcinonia:analysis of 198 cases[J].Hepatobiliary & Pancreatic Diseases International,2006,5(2):278-282. 被引量:5
  • 2YANG Bin,Michael G.House,GUO Mingzhou,James G.Herman,Douglas P.Clark.肝内和肝外胆管癌肿瘤抑制基因启动子甲基化分析[J].胃肠病学和肝病学杂志,2005,14(1):59-65. 被引量:46
  • 3Marco Marzioni,Giammarco Fava,Antonio Benedetti.Nervous and Neuroendocrine regulation of the pathophysiology of cholestasis and of biliary carcinogenesis[J].World Journal of Gastroenterology,2006,12(22):3471-3480. 被引量:8
  • 4Steinberg WM;Gelf R;Anderson KK.Comparison of the sensitivity and specificity of the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas,1986.
  • 5Gogas H;Lofts FJ;Evans TRJ.Are serial measurements of CA-19-9 useful in predicting response to chemotherapy in patients with imperable adenocalrcinoma of the pancreas,1998(02).
  • 6MDChristopher G. Willett BAWilliam J. Daly and MDAndrew L. Warshaw.CA 19-9 is an index of response to neoadjunctive chemoradiation therapy in pancreatic cancer. The American Journal of Surgery . 1996
  • 7Nichols JC,Gores GJ,La Russo NF,et al.Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clinic Proceedings . 1993
  • 8Patel A H,Harnois D M,K lee G G,et al.The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. The American journal of Gastroenterology . 2000
  • 9Ker C G,Chen J S,Lee K T,et al.Assessment of serum and bile levels of CA19-9 and CA125 in cholangitis and bile duct carcinoma. Journal of Gastroenterology . 1991
  • 10Andreas Karachristos M.D., Ph.D.,Nikolaos Scarmeas M.D., M.Sc.,John P. Hoffman M.D..CA 19-9 levels predict results of staging laparoscopy in pancreatic cancer[J]. Journal of Gastrointestinal Surgery . 2005 (9)

共引文献126

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部